Vanderbilt University
Vanderbilt University
Broadie Laboratory
  • Welcome
  • Research
  • People
  • Microscopy
  • Publications
  • Facilities
  • Positions
  • Contact
  • Lab Photos
Vanderbilt University
  • Welcome
  • Research
  • People
  • Microscopy
  • Publications
  • Facilities
  • Positions
  • Contact
  • Lab Photos
  • About
    • This is Vanderbilt
    • Quick Facts
    • University Leadership
    • History
    • Contact
    • A to Z
  • Admissions
    • Undergraduate Admissions
    • Graduate & Professional School Admissions
    • Financial Aid
  • Academics
    • Program Finder
    • Schools & Colleges
    • Residential Colleges
    • Study Abroad
    • Libraries
    • Strategic Plan
  • Research
    • Centers & Institutes
    • Research News
    • Undergraduate Research
    • Graduate School Research
    • VUMC Research
  • Campus Life
    • Housing & Dining
    • Organizations & Identity Centers
    • Athletics
    • Our Hometown - Nashville
  • News & Events
    • Vanderbilt News
    • Research News
    • Vanderbilt Magazine
    • Events

  • Fragile X mental retardation protein is required for programmed cell death and clearance of developmentally-transient peptidergic neurons.

    Fragile X mental retardation protein is required for programmed cell death and clearance of developmentally-transient peptidergic neurons.

    Fragile X syndrome (FXS), caused by loss of fragile X mental retardation 1 (FMR1) gene function, is the most common heritable cause of intellectual disability and autism spectrum disorders. The FMR1 product (FMRP) is an RNA-binding protein best established to function in activity-dependent modulation of synaptic connections. In the Drosophila… Read More

    May. 23, 2018

  • Neural circuit architecture defects in a Drosophila model of Fragile X syndrome are alleviated by minocycline treatment and genetic removal of matrix metalloproteinase.

    Neural circuit architecture defects in a Drosophila model of Fragile X syndrome are alleviated by minocycline treatment and genetic removal of matrix metalloproteinase.

    Fragile X syndrome (FXS), caused by loss of the fragile X mental retardation 1 (FMR1) product (FMRP), is the most common cause of inherited intellectual disability and autism spectrum disorders. FXS patients suffer multiple behavioral symptoms, including hyperactivity, disrupted circadian cycles, and learning and memory deficits. Recently, a study in… Read More

    May. 23, 2018

  • In vivo neuronal function of the fragile X mental retardation protein is regulated by phosphorylation.

    In vivo neuronal function of the fragile X mental retardation protein is regulated by phosphorylation.

    Fragile X syndrome (FXS), caused by loss of the Fragile X Mental Retardation 1 (FMR1) gene product (FMRP), is the most common heritable cause of intellectual disability and autism spectrum disorders. It has been long hypothesized that the phosphorylation of serine 500 (S500) in human FMRP controls its function as… Read More

    May. 23, 2018

  • Structure-function analysis of endogenous lectin mind-the-gap in synaptogenesis.

    Structure-function analysis of endogenous lectin mind-the-gap in synaptogenesis.

    Mind-the-Gap (MTG) is required for neuronal induction of Drosophila neuromuscular junction (NMJ) postsynaptic domains, including glutamate receptor (GluR) localization. We have previously hypothesized that MTG is secreted from the presynaptic terminal to reside in the synaptic cleft, where it binds glycans to organize the heavily glycosylated, extracellular synaptomatrix required for… Read More

    May. 23, 2018

  • Matrix metalloproteinases and minocycline: therapeutic avenues for fragile X syndrome.

    Matrix metalloproteinases and minocycline: therapeutic avenues for fragile X syndrome.

    Fragile X syndrome (FXS) is the most common known genetic form of intellectual disability and autism spectrum disorders. FXS patients suffer a broad range of other neurological symptoms, including hyperactivity, disrupted circadian activity cycles, obsessive-compulsive behavior, and childhood seizures. The high incidence and devastating effects of this disease state make… Read More

    May. 23, 2018

  • A targeted glycan-related gene screen reveals heparan sulfate proteoglycan sulfation regulates WNT and BMP trans-synaptic signaling.

    A targeted glycan-related gene screen reveals heparan sulfate proteoglycan sulfation regulates WNT and BMP trans-synaptic signaling.

    A Drosophila transgenic RNAi screen targeting the glycan genome, including all N/O/GAG-glycan biosynthesis/modification enzymes and glycan-binding lectins, was conducted to discover novel glycan functions in synaptogenesis. As proof-of-product, we characterized functionally paired heparan sulfate (HS) 6-O-sulfotransferase (hs6st) and sulfatase (sulf1), which bidirectionally control HS proteoglycan (HSPG) sulfation. RNAi knockdown of… Read More

    May. 23, 2018

  • Jelly Belly trans-synaptic signaling to anaplastic lymphoma kinase regulates neurotransmission strength and synapse architecture.

    Jelly Belly trans-synaptic signaling to anaplastic lymphoma kinase regulates neurotransmission strength and synapse architecture.

    In Drosophila, the secreted signaling molecule Jelly Belly (Jeb) activates anaplastic lymphoma kinase (Alk), a receptor tyrosine kinase, in multiple developmental and adult contexts. We have shown previously that Jeb and Alk are highly enriched at Drosophila synapses within the CNS neuropil and neuromuscular junction (NMJ) and postulated a conserved… Read More

    May. 23, 2018

  • An essential Drosophila glutamate receptor subunit that functions in both central neuropil and neuromuscular junction.

    An essential Drosophila glutamate receptor subunit that functions in both central neuropil and neuromuscular junction.

    A Drosophila forward genetic screen for mutants with defective synaptic development identified bad reception (brec). Homozygous brec mutants are embryonic lethal, paralyzed, and show no detectable synaptic transmission at the glutamatergic neuromuscular junction (NMJ). Genetic mapping, complementation tests, and genomic sequencing show that brec mutations disrupt a previously uncharacterized ionotropic… Read More

    May. 23, 2018

  • Rolling blackout is required for synaptic vesicle exocytosis.

    Rolling blackout is required for synaptic vesicle exocytosis.

    Rolling blackout (RBO) is a putative transmembrane lipase required for phospholipase C-dependent phosphatidylinositol 4,5-bisphosphate-diacylglycerol signaling in Drosophila neurons. Conditional temperature-sensitive (TS) rbo mutants display complete, reversible paralysis within minutes, demonstrating that RBO is acutely required for movement. RBO protein is localized predominantly in presynaptic boutons at neuromuscular junction (NMJ) synapses… Read More

    May. 23, 2018

  • Temperature-sensitive paralytic mutants: insights into the synaptic vesicle cycle.

    Temperature-sensitive paralytic mutants: insights into the synaptic vesicle cycle.

    Forward genetic screens have identified numerous proteins with critical roles in neurotransmission. One particularly fruitful screening target in Drosophila has been TS (temperature-sensitive) paralytic mutants, which have revealed proteins acutely required in neuronal signalling. In the present paper, we review recent insights and current questions from one recently cloned TS… Read More

    May. 23, 2018

Previous
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 18
Next
Vanderbilt University
  • University Leadership
  • Residential Colleges
  • This Is Vanderbilt
  • Research@Vanderbilt
  • Working at Vanderbilt
  • Events
  • Logins
  • Campus Map
  • Media Resources

Nashville, Tennessee 37240

615-322-7311 • Contact Us

Vanderbilt University’s Online Privacy Notice

  • Twitter
  • Facebook
  • LinkedIn
  • Instagram
  • YouTube
  • TikTok
  • Flickr

Vanderbilt University is committed to the principle of equal opportunity. Vanderbilt University does not discriminate against individuals on the basis of their race, sex, sexual orientation, gender identity, religion, color, national or ethnic origin, age, disability, military service, or genetic information in its administration of educational policies, programs, or activities; admissions policies; scholarship and loan programs; athletic or other University-administered programs; or employment. Accessibility information. Vanderbilt®, Vanderbilt University® and the Vanderbilt logos are trademarks of The Vanderbilt University. Site Development: Digital Strategies (Communications and Marketing.) © 2025